Literature DB >> 6099892

The olfactory bulbectomized rat as a model of depression.

B E Leonard.   

Abstract

The behavioural effects of bilateral olfactory bulbectomy in the rat are summarized and evidence presented to show that the deficits in active and passive avoidance behaviour, and hyperactivity in a novel stressful environment, can be specifically attenuated by chronic administration of antidepressants. The usefulness of the bulbectomized rat model in the detection of potential antidepressants and in giving an insight into the possible mechanisms of action of these drugs is summarized.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6099892

Source DB:  PubMed          Journal:  Pol J Pharmacol Pharm        ISSN： 0301-0244


  11 in total

Review 1.  Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?

Authors:  Shannon K Crowley; Susan S Girdler
Journal:  Psychopharmacology (Berl)       Date:  2014-04-23       Impact factor: 4.530

Review 2.  Olfaction as a marker for depression.

Authors:  Ilona Croy; Thomas Hummel
Journal:  J Neurol       Date:  2016-07-08       Impact factor: 4.849

3.  Proceedings of the British Pharmacological Society. 18th-20th December 1985. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

Review 4.  Molecular Mechanisms Underlying the Anti-depressant Effects of Resveratrol: a Review.

Authors:  Marcos Roberto de Oliveira; Aline Lukasievicz Chenet; Adriane Ribeiro Duarte; Giselli Scaini; João Quevedo
Journal:  Mol Neurobiol       Date:  2017-07-10       Impact factor: 5.590

Review 5.  Overlapping neurobiology of learned helplessness and conditioned defeat: implications for PTSD and mood disorders.

Authors:  Sayamwong E Hammack; Matthew A Cooper; Kimberly R Lezak
Journal:  Neuropharmacology       Date:  2011-03-09       Impact factor: 5.250

6.  SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19.

Authors:  Geidy E Serrano; Jessica E Walker; Cécilia Tremblay; Ignazio S Piras; Matthew J Huentelman; Christine M Belden; Danielle Goldfarb; David Shprecher; Alireza Atri; Charles H Adler; Holly A Shill; Erika Driver-Dunckley; Shyamal H Mehta; Richard Caselli; Bryan K Woodruff; Chadwick F Haarer; Thomas Ruhlen; Maria Torres; Steve Nguyen; Dasan Schmitt; Steven Z Rapscak; Christian Bime; Joseph L Peters; Ellie Alevritis; Richard A Arce; Michael J Glass; Daisy Vargas; Lucia I Sue; Anthony J Intorcia; Courtney M Nelson; Javon Oliver; Aryck Russell; Katsuko E Suszczewicz; Claryssa I Borja; Madison P Cline; Spencer J Hemmingsen; Sanaria Qiji; Holly M Hobgood; Joseph P Mizgerd; Malaya K Sahoo; Haiyu Zhang; Daniel Solis; Thomas J Montine; Gerald J Berry; Eric M Reiman; Katharina Röltgen; Scott D Boyd; Benjamin A Pinsky; James L Zehnder; Pierre Talbot; Marc Desforges; Michael DeTure; Dennis W Dickson; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2022-08-16       Impact factor: 3.148

Review 7.  Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.

Authors:  D Murdoch; D McTavish
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

8.  Sex and Feeding Status Differently Affect Natural Reward Seeking Behavior in Olfactory Bulbectomized Rats.

Authors:  Jana Ruda-Kucerova; Mary Tresa Zanda; Petra Amchova; Walter Fratta; Liana Fattore
Journal:  Front Behav Neurosci       Date:  2018-10-30       Impact factor: 3.558

9.  Light affects behavioral despair involving the clock gene Period 1.

Authors:  Iwona Olejniczak; Jürgen A Ripperger; Federica Sandrelli; Anna Schnell; Laureen Mansencal-Strittmatter; Katrin Wendrich; Ka Yi Hui; Andrea Brenna; Naila Ben Fredj; Urs Albrecht
Journal:  PLoS Genet       Date:  2021-07-08       Impact factor: 5.917

Review 10.  Modelling cognitive affective biases in major depressive disorder using rodents.

Authors:  Claire A Hales; Sarah A Stuart; Michael H Anderson; Emma S J Robinson
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.